We recently reported that SETD2 inactivation in ccRCC expressing wild-type VHL sensitizes cells to STF-62247 resulting in a cell cycle block in S-phase (Johnson and Turcotte, 2025). Here, SETD2 is linked to nonpapillary renal cell carcinoma.